[ad_1] Global biopharmaceutical company Biocon announced on Friday a partnership with Juno Pharmaceuticals, a specialty pharmaceutical firm based in Canada, for the commercialisation of Liraglutide, a drug-device combination intended for…
[ad_1] Global biopharmaceutical company Biocon announced on Friday a partnership with Juno Pharmaceuticals, a specialty pharmaceutical firm based in Canada, for the commercialisation of Liraglutide, a drug-device combination intended for…